XOMAP FY 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38M+29.9% YoY

Gross Profit

$38M99.6% margin

Operating Income

$18M45.9% margin

Net Income

$16M41.4% margin

EPS (Diluted)

$0.65

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

-$4M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$167M

Total Liabilities

$25M

Stockholders' Equity

$142M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$29M	+29.9%
Gross Profit	$38M	$29M	+30.0%
Operating Income	$18M	$12M	+41.2%
Net Income	$16M	$13M	+18.8%